Hormonal, hypothalamic and striatal responses to reduced body weight gain are attenuated in anorectic rats bearing small tumors

Brain, Behavior, and Immunity

Volumn 25, Issue 4, 2011, Pages 777-786

  Pourtau, Line ^a   Leemburg, Susan ^a   Roux, Pascale ^a   Leste Lasserre, Thierry ^b   Costaglioli, Patricia ^c   Garbay, Bertrand ^c   Drutel, Guillaume ^b   Konsman, Jan Pieter ^a  

^a CNRS   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Agouti related peptide; Anorexia; Cancer; Endothelin; Gamma aminobutyric acid; Ghrelin; Hypothalamus; Leptin; Prostaglandin D synthase; Ventral striatum

Indexed keywords

AGOUTI RELATED PROTEIN; GHRELIN; LEPTIN; MESSENGER RNA; PROSTAGLANDIN D SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY MASS; BUFFALO RAT; CONTROLLED STUDY; CORPUS STRIATUM; DIET RESTRICTION; FOOD INTAKE; HEPATOMA CELL; HORMONE RESPONSE; HYPOTHALAMUS FUNCTION; MALE; MICROARRAY ANALYSIS; MORRIS HEPATOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN;

ADAPTATION, PHYSIOLOGICAL; AGOUTI-RELATED PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; APPETITE REGULATION; BASAL GANGLIA; BODY WEIGHT; CACHEXIA; CARCINOMA, HEPATOCELLULAR; CYTOKINES; DISEASE MODELS, ANIMAL; EATING; GENE EXPRESSION REGULATION; GHRELIN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; LEPTIN; LIPOCALINS; LIVER NEOPLASMS; MALE; MATCHED-PAIR ANALYSIS; NEOPLASMS, EXPERIMENTAL; PAIN PERCEPTION; RATS; RATS, INBRED BUF; RNA, MESSENGER; SPINAL CORD; WEIGHT LOSS;

EID: 79954954891     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.004     Document Type: Article

References (68)

1. Bagnato A., Spinella F., Rosano L. The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy. Can. J. Physiol. Pharmacol. 2008, 86:473-484.
2. Bing C., Taylor S., Tisdale M.J., Williams G. Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. J. Neurochem. 2001, 79:1004-1012.
3. Bodnar R.J., Glass M.J., Ragnauth A., Cooper M.L. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 1995, 700:205-212.
4. Bosaeus I., Daneryd P., Svanberg E., Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int. J. Cancer 2001, 93:380-383.
5. Broberger C., Johansen J., Johansson C., Schalling M., Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. USA 1998, 95:15043-15048.
6. Chance W.T., Dayal R., Friend L.A., Thomas I., Sheriff S. Continuous intravenous infusion of ghrelin does not stimulate feeding in tumor-bearing rats. Nutr. Cancer 2008, 60:75-90.
7. Chance W.T., Sheriff S., Dayal R., Balasubramaniam A. Refractory hypothalamic alpha-MSH satiety and AGRP feeding systems in rats bearing MCA sarcomas. Peptides 2003, 24:1909-1919.
8. Chance W.T., Sheriff S., Moore J., Peng F., Balasubramaniam A. Reciprocal changes in hypothalamic receptor binding and circulating leptin in anorectic tumor-bearing rats. Brain Res. 1998, 803:27-33.
9. Chance W.T., Xiao C., Dayal R., Sheriff S. Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats. Peptides 2007, 28:295-301.
10. Coggeshall R.E. Fos, nociception and the dorsal horn. Prog. Neurobiol. 2005, 77:299-352.
11. Costa G. Cachexia, the metabolic component of neoplastic diseases. Cancer Res. 1977, 37:2327-2335.
12. Cunningham M.E., Huribal M., Bala R.J., McMillen M.A. Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines. Crit. Care Med. 1997, 25:958-964.
13. Davis M.P., Dreicer R., Walsh D., Lagman R., LeGrand S.B. Appetite and cancer-associated anorexia: a review. J. Clin. Oncol. 2004, 22:1510-1517.
14. De Vriese C., Hacquebard M., Gregoire F., Carpentier Y., Delporte C. Ghrelin interacts with human plasma lipoproteins. Endocrinology 2007, 148:2355-2362.
15. Dnistrian A.M., Barclay M., Terebus-Kekish O., Archibald F.M., Morris H.P. Serum lipoproteins in rats bearing Morris hepatomas of different degrees of differentiation. Cancer Biochem. Biophys. 1979, 3:81-84.
16. Dulloo A.G., Seydoux J., Jacquet J. Adaptive thermogenesis and uncoupling proteins: a reappraisal of their roles in fat metabolism and energy balance. Physiol. Behav. 2004, 83:587-602.
17. Fekete C., Singru P.S., Sanchez E., Sarkar S., Christoffolete M.A., Riberio R.S., Rand W.M., Emerson C.H., Bianco A.C., Lechan R.M. Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. Endocrinology 2006, 147:520-529.
18. Feuz A., Rapin C.H. An observational study of the role of pain control and food adaptation of elderly patients with terminal cancer. J. Am. Diet. Assoc. 1994, 94:767-770.
19. Garbay B., Tautu M.T., Costaglioli P. Low level of pathogenesis-related protein 1 mRNA expression in 15-day-old Arabidopsis cer6-2 and cer2 eceriferum mutants. Plant Sci. 2007, 172:299-305.
20. Garcia J.M., Garcia-Touza M., Hijazi R.A., Taffet G., Epner D., Mann D., Smith R.G., Cunningham G.R., Marcelli M. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J. Clin. Endocrinol. Metab. 2005, 90:2920-2926.
21. Garcia J.M., Iyer D., Poston W.S., Marcelli M., Reeves R., Foreyt J., Balasubramanyam A. Rise of plasma ghrelin with weight loss is not sustained during weight maintenance. Obesity (Silver Spring) 2006, 14:1716-1723.
22. Hans G., Deseure K., Adriaensen H. Endothelin-1-induced pain and hyperalgesia: a review of pathophysiology, clinical manifestations and future therapeutic options. Neuropeptides 2008, 42:119-132.
23. Hans G., Schmidt B.L., Strichartz G. Nociceptive sensitization by endothelin-1. Brain Res. Rev. 2009, 60:36-42.
24. Howard J.M., Pidgeon G.P., Reynolds J.V. Leptin and gastro-intestinal malignancies 2010, Obes, Rev.
25. Kalyuzhny A.E., Wessendorf M.W. Relationship of mu- and delta-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J. Comp. Neurol. 1998, 392:528-547.
26. Kandov Y., Israel Y., Kest A., Dostova I., Verasammy J., Bernal S.Y., Kasselman L., Bodnar R.J. GABA receptor subtype antagonists in the nucleus accumbens shell and ventral tegmental area differentially alter feeding responses induced by deprivation, glucoprivation and lipoprivation in rats. Brain Res. 2006, 1082:86-97.
27. Kergozien S., Delcros J.G., Jouan H., Moulinoux J.P. Induction of Fos protein expression in spinal cord neurons of tumour-bearing rats. Br. J. Cancer 1999, 80:1512-1517.
28. Konsman J.P., Blomqvist A. Forebrain patterns of c-Fos and FosB induction during cancer-associated anorexia-cachexia in rat. Eur. J. Neurosci. 2005, 21:2752-2766.
29. Konsman J.P., Dantzer R. How the immune and nervous systems interact during disease-associated anorexia. Nutrition 2001, 17:664-668.
30. Konsman J.P., Kelley K., Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience 1999, 89:535-548.
31. Lasheen W., Walsh D. The cancer anorexia-cachexia syndrome: myth or reality?. Support. Care Cancer 2010, 18:265-272.
32. Liu H., Kishi T., Roseberry A.G., Cai X., Lee C.E., Montez J.M., Friedman J.M., Elmquist J.K. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J. Neurosci. 2003, 23:7143-7154.
33. Lopez-Soriano J., Carbo N., Tessitore L., Lopez-Soriano F.J., Argiles J.M. Leptin and tumor growth in rats. Int. J. Cancer 1999, 81:726-729.
34. Lu D., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R.P., Wilkison W.O., et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371:799-802.
35. Luis-Delgado O.E., Barrot M., Rodeau J.L., Ulery P.G., Freund-Mercier M.J., Lasbennes F. The transcription factor DeltaFosB is recruited by inflammatory pain. J. Neurochem. 2006, 98:1423-1431.
36. Lundholm K., Gunnebo L., Korner U., Iresjo B.M., Engstrom C., Hyltander A., Smedh U., Bosaeus I. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer 2010, 116:2044-2052.
37. Lundholm K., Korner U., Gunnebo L., Sixt-Ammilon P., Fouladiun M., Daneryd P., Bosaeus I. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin. Cancer Res. 2007, 13:2699-2706.
38. Maltoni M., Fabbri L., Nanni O., Scarpi E., Pezzi L., Flamini E., Riccobon A., Derni S., Pallotti G., Amadori D. Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients [see comments]. Support. Care Cancer 1997, 5:130-135.
39. Marks D.L., Butler A.A., Turner R., Brookhart G., Cone R.D. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 2003, 144:1513-1523.
40. Marks D.L., Ling N., Cone R.D. Role of the central melanocortin system in cachexia. Cancer Res. 2001, 61:1432-1438.
41. McMillen M.A., Huribal M., Cunningham M.E., Kumar R., Sumpio B.E. Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6. Crit. Care Med. 1995, 23:34-40.
42. Meuser T., Pietruck C., Radbruch L., Stute P., Lehmann K.A., Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001, 93:247-257.
43. Moley J.F., Morrison S.D., Gorschboth C.M., Norton J.A. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res. 1988, 48:2784-2787.
44. Molotkov A., Satoh M., Tohyama C. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Lett. 1998, 132:187-192.
45. Monnikes H., Ruter J., Konig M., Grote C., Kobelt P., Klapp B.F., Arnold R., Wiedenmann B., Tebbe J.J. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors. Brain Res. 2003, 966:253-264.
46. Morash B., Johnstone J., Leopold C., Li A., Murphy P., Ur E., Wilkinson M. The regulation of leptin gene expression in the C6 glioblastoma cell line. Mol. Cell Endocrinol. 2000, 165:97-105.
47. Morrison S.D. Diurnal distribution of motor activity and feeding during growth of tumors. Cancer Res. 1974, 34:1632-1635.
48. Mosby T.T., Barr R.D., Pencharz P.B. Nutritional assessment of children with cancer. J. Pediatr. Oncol. Nurs. 2009, 26:186-197.
49. Narayan K.A., Morris H.P. In vitro synthesis of rat serum lipoproteins and proteins by Morris hepatoma 7777. FEBS Lett. 1972, 27:311-315.
50. Nething J., Ringwald-Smith K., Williams R., Hancock M.L., Hale G.A. Establishing the use of body mass index as an indicator of nutrition risk in children with cancer. JPEN J. Parenter Enteral Nutr. 2007, 31:53-57.
51. Oertel W.H., Mugnaini E. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 1984, 47:233-238.
52. Ohinata K., Takagi K., Biyajima K., Fujiwara Y., Fukumoto S., Eguchi N., Urade Y., Asakawa A., Fujimiya M., Inui A., Yoshikawa M. Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice. FEBS Lett. 2008, 582:679-684.
53. Ohtori S., Takahashi K., Chiba T., Takahashi Y., Yamagata M., Sameda H., Moriya H. Fos expression in the rat brain and spinal cord evoked by noxious stimulation to low back muscle and skin. Spine 2000, 25:2425-2430.
54. Oliver P., Pico C., Palou A. Ontogenesis of leptin expression in different adipose tissue depots in the rat. Pflugers Arch. 2001, 442:383-390.
55. Pfab T., Stoltenburg-Didinger G., Trautner C., Godes M., Bauer C., Hocher B. The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo. Br. J. Pharmacol. 2004, 141:215-222.
56. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
57. Ruetten H., Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J. Physiol. Pharmacol. 1997, 48:675-688.
58. Seo Y.J., Kwon M.S., Choi S.S., Han E.J., Jung J.S., Choi H.W., Park S.H., Jang J.E., Suh H.W. Characterization of the hypothalamic proopiomelanocortin gene and beta-endorphin expression in the hypothalamic arcuate nucleus of mice elicited by inflammatory pain. Neuroscience 2008, 152:1054-1066.
59. Seoane L.M., Lopez M., Tovar S., Casanueva F.F., Senaris R., Dieguez C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 2003, 144:544-551.
60. Steele T.D., Bryant H.U., Malven P.V., Yim G.K. Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing rats. Pharmacol. Biochem. Behav. 1988, 29:541-545.
61. Sucajtys-Szulc E., Turyn J., Goyke E., Korczynska J., Stelmanska E., Slominska E., Smolenski R.T., Rutkowski B., Swierczynski J. Differential effect of prolonged food restriction and fasting on hypothalamic malonyl-CoA concentration and expression of orexigenic and anorexigenic neuropeptides genes in rats. Neuropeptides 2010, 44:17-23.
62. Teunissen S.C., Wesker W., Kruitwagen C., de Haes H.C., Voest E.E., de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J. Pain Symptom Manage. 2007, 34:94-104.
63. Tisdale M.J. Cachexia in cancer patients. Nat. Rev. Cancer 2002, 2:862-871.
64. Wang W., Andersson M., Iresjo B.M., Lonnroth C., Lundholm K. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int. J. Oncol. 2006, 28:1393-1400.
65. Wirth M.M., Giraudo S.Q. Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding. Peptides 2000, 21:1369-1375.
66. Wolf I., Sadetzki S., Kanety H., Kundel Y., Pariente C., Epstein N., Oberman B., Catane R., Kaufman B., Shimon I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006, 106:966-973.
67. Xu Y., Jones J.E., Kohno D., Williams K.W., Lee C.E., Choi M.J., Anderson J.G., Heisler L.K., Zigman J.M., Lowell B.B., Elmquist J.K. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron 2008, 60:582-589.
68. Yamashita A., Watanabe Y., Hayaishi O. Autoradiographic localization of a binding protein(s) specific for prostaglandin D2 in rat brain. Proc. Natl. Acad. Sci. USA 1983, 80:6114-6118.